Replies to post #185 on Recursion Pharmaceuticals Inc (RXRX)

[camelion]

Next week, it will likely push through $7 again. Trouble is, swing it or hold for gold since their physical trial data could likely being positive will push it double digits.The earnings report we may see revenues increase again, while net earnings will likely be negative. If they beat Q2's net earnings per share $-0.42, that would look positive. Good luck  with $RXRX👍 Its  wild horse